Gene expression profiles in Hispanic patients with early-onset gastric cancer.

Authors

null

Michelle R Ju

UT Southwestern Medical Center, Dallas, TX;

Michelle R Ju , Changjin Hong , John D Karalis , Suntrea Hammer , Matthew R. Porembka , Tae Hyun Hwang , Sam C. Wang

Organizations

UT Southwestern Medical Center, Dallas, TX; , Mayo Clinic, Jacksonville, FL; , University of Texas Southwestern Medical Center, Dallas, TX;

Research Funding

No funding received
None.

Background: A larger proportion of Hispanic gastric cancer patients are diagnosed at a young age than patients of other ethnicities. Despite diagnosis at an early age, young Hispanic patients also present more frequently with advanced disease. Whether there are molecular differences between tumors from young and old Hispanic gastric cancer patients is unknown. Methods: We performed RNA-sequencing on pre-treatment tumor samples of gastric cancer patients of self-identified Hispanic ethnicity. We stratified patients into two groups: <50 years and ≥50 years. Differentially expressed genes between groups were detected using the DESeq2 package (RStudio). We performed Gene Set Enrichment Analysis (GSEA) to identify pathways that were uniquely overexpressed in each age group. Results: 57 patients were included in our study. 23 patients were <50 years and 33 patients were ≥50 years. Comparison of the top 10% most differentially expressed genes showed no clustering based on age. However, visual inspection of the top 40 most differentially expressed genes revealed 2 distinct patterns of gene expression between age groups. GSEA revealed upregulation of DNA replication, cell cycle, and DNA repair pathways in the younger patients The tumors in younger patients also had upregulation of multiple immune activation pathways. Cancers from older patients had upregulation of programmed cell death pathways. Conclusions: Early-onset gastric cancer in Hispanic patients may represent a distinct biologic process.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 464)

DOI

10.1200/JCO.2023.41.4_suppl.464

Abstract #

464

Poster Bd #

L10

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Prevalence of modifiable risk factors of Hispanic adult patients admitted with gastric cancer in the US.

First Author: Alejandro Nieto Dominguez

Abstract

2023 ASCO Annual Meeting

Early onset gastric cancer: An analysis of epidemiological and environmental risk factors.

First Author: Erfan Zarrinkhoo

Abstract

2023 ASCO Gastrointestinal Cancers Symposium

Disparities and outcomes in young adults admitted for gastric cancer in the US.

First Author: Rafaella Litvin